Journal Article
Having a greater knowledge of the amount of marijuana consumed and produced in each country will sustain substantially informed debates both sides of the border.
Journal Article
Having a greater knowledge of the amount of marijuana consumed and produced in each country will sustain substantially informed debates both sides of the border.
News Release
Efforts by the United States to combat Latin American cocaine smugglers have disrupted drug supplies and captured key cartel leaders, but they have not significantly reduced the region's overall narcotics trade.
Report
Efforts by the United States to combat Latin American cocaine smugglers have disrupted drug supplies and captured key cartel leaders, but they have not significantly reduced the region's overall narcotics trade.
Report
This study provides evidence on potential economic impact of policies designed to increase the price of alcoholic drinks on consumers, producers and retailers in the UK. Policy-makers used recommendations to implement a new pricing policy.
Journal Article
This paper provides a look back at the creation, evolution and growth of the RAND Drug Policy Research Center (DPRC).
Journal Article
This study provides descriptive information about 1,655 applicants in California who sought a physician's recommendation for medical marijuana, the conditions for which they sought treatment, and the diagnoses made by the physicians.
News Release
Legalizing marijuana in California will not dramatically reduce the drug revenues collected by Mexican drug trafficking organizations from sales to the United States.
Report
The only scenario where marijuana legalization in California could substantially reduce the revenue of the drug trafficking organizations is if high-potency, California-produced marijuana is smuggled to other U.S. states at prices that are lower than those of current Mexican supplies.
Research Brief
Discusses whether legalizing marijuana in California would reduce the revenues of Mexican drug trafficking organizations and related violence.
Report
Testimony presented by Beau Kilmer before the California State Assembly Public Safety Committee and California State Senate Public Safety Committee on September 21, 2010.
Past Event
Beau Kilmer, codirector of the RAND Drug Policy Research Center, will discuss the projected revenues, costs, and effects on price and use that may come from legalizing, regulating, and taxing marijuana in California.
News Release
Legalizing the production and distribution of marijuana in California could cut the price of the drug by as much as 80 percent and increase consumption.
Report
Legalizing the production and distribution of marijuana in California could cut the price of the drug by as much as 80 percent and increase consumption. While the state has estimated taxing legal marijuana could raise more than $1 billion in revenue, this could be dramatically higher or lower based on a number of factors.
Research Brief
Legalizing marijuana in California would lead to a substantial decline in price, but there is much uncertainty about legalization's effect on public budgets and consumption; even minor changes in assumptions lead to major differences in outcomes.
Report
Testimony presented before the House Oversight and Government Reform Committee, Subcommittee on Domestic Policy on April 14, 2010.
Research Brief
To better understand illegal drug markets and supply-reduction efforts in the European Union, data on purity-adjusted prices must be collected. Member states can learn more about supply reduction by changing how they report seizure data.
Report
Describes how the British Government's narrower focus of problem drug use on most significant harms may be useful, but carries risks and drawbacks. We find the UK Drug Strategy draws on robust evidence for drug treatment and drug-related crime.
Journal Article
This study of national survey and state policy data found that restrictive alcohol sales policies may reduce drinking and transmission risk in HIV-positive populations.
Journal Article
Many California local health jurisdictions with significant numbers of HIV cases have approved disease prevention demonstration projects, which permit limited sale of syringes to adults without a prescription
RAND® is a registered trademark. Copyright © 1994-2013 RAND Corporation. Last Modified: November 09, 2012 Site Feedback »